Associated Papers
Impact of Renin-Angiotensin-Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review.
Adhikari A et al.
International Journal of Hypertension, 2025
Pertinence between risk of preeclampsia and the renin-angiotensin-aldosterone system (RAAS) gene polymorphisms: an updated meta-analysis based on 73 studies.
Wang X et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 2023
Association of -344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension.
Wang L et al.
The Journal of International Medical Research, 2020
Are genetic polymorphisms in the renin-angiotensin-aldosterone system associated with essential hypertension? Evidence from genome-wide association studies.
Ji LD et al.
Journal of Human Hypertension, 2017
Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase.
Ichikawa M et al.
Acta Diabetologica, 2014
Lack of an association between CYP11B2 C-344T gene polymorphism and ischemic stroke: a meta-analysis of 7,710 subjects.
Pi Y et al.
Plos One, 2013
Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy.
Huang HD et al.
Chinese Medical Journal, 2010
Pharmacogenetics in heart failure: promises and challenges.
de Boer RA et al.
Expert Opinion on Pharmacotherapy, 2009
Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
Volkan-Salanci B et al.
Journal of the Renin-angiotensin-aldosterone System : Jraas, 2009
Association of the -344T/C aldosterone synthase gene variant with essential hypertension.
Hlubocká Z et al.
Physiological Research, 2009
Genetic polymorphisms and the risk of accelerated renal function decline in women.
Cooper Worobey C et al.
Plos One, 2009
Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Patel TV et al.
Journal of Hypertension, 2008
Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors.
Forman JP et al.
Journal of Clinical Hypertension (greenwich, Conn.), 2008
Gene polymorphisms of the renin-angiotensin-aldosterone system and angiotensin II type 1-receptor activating antibodies in renal rejection.
Zhang G et al.
The Tohoku Journal of Experimental Medicine, 2007
Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age.
Franco E et al.
Bmc Medical Genetics, 2007
Effects of angiotensinogen and angiotensin II type I receptor genes on blood pressure and left ventricular mass trajectories in multiethnic youth.
Wang X et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies, 2006
Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China.
Tang W et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2006
[Relationship between the aldosterone synthase (CYP11B2)-344C/T polymorphism and small artery compliance].
Li XL et al.
Zhonghua Xin Xue Guan Bing Za Zhi, 2005
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension.
Fabris B et al.
Journal of Hypertension, 2005
Genetic variation in CYP11B2 and AT1R influences heart rate variability conditional on sodium excretion.
Stolarz K et al.
Hypertension (dallas, Tex. : 1979), 2004
A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study.
Kikuya M et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2003
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Kurland L et al.
Journal of Hypertension, 2002
Evaluation of selected polymorphisms of the Mendelian hypertensive disease genes in the Japanese population.
Sugiyama T et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2001
Effects of antihypertensive drugs and gene variants in the renin-angiotensin system.
Katsuya T et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2001
Polymorphisms in the renin-angiotensin system and endothelium-dependent vasodilation in normotensive subjects.
Kurland L et al.
Clinical Physiology (oxford, England), 2001
Genetic determination of plasma aldosterone levels in essential hypertension.
Pojoga L et al.
American Journal of Hypertension, 1998